(Q36845392)

16 August 2017

1 reference

title

Cytokines and cancer: experimental systems (English)

1 reference

16 August 2017

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

16 November 2022

author name string

T. Blankenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755987

16 November 2022

D. A. Rowley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755987

16 November 2022

H. Schreiber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755987

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1755987

16 November 2022

publication date

1 October 1991

1 reference

full work available at URL

16 August 2017

https://api.elsevier.com/content/article/PII:095279159190098L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

https://api.elsevier.com/content/article/PII:095279159190098L?httpAccept=text/plain

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Current Opinion in Immunology

16 November 2022

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

694-698

1 reference

Lymphokine gene therapy for cancer

16 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2

16 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

16 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Murine interleukin-4 displays potent anti-tumor activity in vivo

16 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4.

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

16 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Tumors secreting human TNF/cachectin induce cachexia in mice

16 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity

16 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

16 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity

16 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Retroviral transfer and expression of the interleukin-3 gene in hemopoietic cells.

16 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity

16 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

16 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line

16 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

16 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

Autocrine growth factors and tumourigenic transformation

16 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90098-L

16 November 2022

Identifiers

1 reference

16 August 2017

1 reference